Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New gel injection aims to soothe sore tendons

NCT ID NCT06681051

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Sep 17, 2026 · Updated 5 times

Summary

This study is testing a gel called OSTENIL TENDON to see if it safely reduces pain and improves movement in people with tendon problems. Researchers will enroll 84 adults with one of four types of tendinopathy. The main goal is to measure pain changes three months after treatment.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 84 people

The number the study aims to enrol. It can still change while the study runs.

Started

Nov 2024

Expected to finish

Oct 2026

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Patients over 18 years of age with symptomatic tendinopathy (patella tendon, peroneal tendon, medial epicondylus humeri or iliotibial band) and a recommendation for OSTENIL® TENDON treatment.

Ages

18 to 99 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patient aged between 18 and 99 years * Diagnosis of symptomatic tendinopathy (patella tendon, peroneal tendon, medial epicondylus humeri or iliotibial band) * Physician's recommendation to use OSTENIL® TENDON prior to recruitment * Signed informed consent Exclusion Criteria: * Presence of any contra-indication or precautionary condition listed in the instructions for use, i.e., * Ascertained hypersensitivity to any of the OSTENIL® TENDON constituents * Known pregnancy or breast feeding * Acute trauma * Use of the following treatments (the given time intervals refer to the date of inclusion): * Local\* OSTENIL® TENDON or other hyaluronic acid (HA) treatment within the last 6 months * Local\* platelet-rich plasma (PRP) treatment within the last 3 months * Local\* corticosteroid treatment (without time restriction) * Local\* extracorporeal shock wave therapy (ESWT) within the last 4 weeks * Local\* phytotherapy (e.g., Traumeel®) within the last 4 weeks * Local\* surgical intervention (without time restriction) * Systemic corticosteroid treatment within the last 4 weeks * Repeated use of non-steroidal anti-inflammatory drugs (NSAID) and/or other analgesics within the last week * Physiotherapy (therapeutic exercises and physical therapy), ortheses, transcutaneous electrical nerve stimulation (TENS) or acupuncture within the last week * Diagnosis of chronic inflammatory disease (e.g. rheumatoid arthritis, Bechterew disease, Crohn's disease, etc.) prior to inclusion * Participation in a clinical investigation within the last 6 months * Vulnerable patient (individual who is unable to fully understand all aspects of the study that are relevant to the decision to participate, or who could be manipulated or unduly influenced as a result of a compromised position, expectation of benefits or fear of retaliatory response \[including persons needing legally designated representatives, illiterate persons or persons with insufficient knowledge of local language\]) (\* local refers to the treatment of the study-relevant tendon)

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Patellar tendinopathy are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The study's own enquiry address

    This study publishes an address for enquiries. See it below .

  2. The places running it

    3 sites. The list below names each one and where it is.

  3. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  4. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • ATOS MVZ meviva Berlin

    COMPLETED

    Berlin, 10627, Germany

  • Gemeinschaftspraxis Dr. Bierke

    COMPLETED

    Berlin, 14197, Germany

  • Orthopädie am Kiesteich

    RECRUITING

    Berlin, 13589, Germany

    Contact Email: •••••@•••••

  • Orthopädische Gemeinschaftspraxis ÜBAG

    RECRUITING

    Berlin, State of Berlin, 14195, Germany

  • Orthopädische Praxis Dr. Fischer

    COMPLETED

    Potsdam, 14482, Germany

  • Orthopädisches Versorgungszentrum und Interdisziplinäres Schmerzzentrum Zehlendorf

    RECRUITING

    Berlin, State of Berlin, 14195, Germany

More trials for these conditions

Other studies related to the condition(s) this trial covers.